Science
Mechanism of Action
This ingredient functions through a dual-action pathway: it activates the COL1A1 gene to stimulate the production of Type I collagen while simultaneously suppressing the synthesis of Matrix Metalloproteinase-1 (MMP-1). By inhibiting this collagen-degrading enzyme and neutralizing oxidative stress via its caffeoyl moiety, it preserves existing skin density and promotes a firmer, more resilient complexion.
Research
Clinical Evidence
High confidence0.05%
Key findings
- 01 In vitro testing on human dermal fibroblasts demonstrated that a 0.05% concentration increased Type I Collagen mRNA expression by 38.44% and reduced collagenase (MMP-1) expression by 21.05%.
Transparency
Dusting Analysis
Because peptides are effective at very low concentrations, brands often include them at 'label claim' levels (under 0.01%) that fail to trigger the significant collagen synthesis observed at the 0.05% clinical benchmark.
The Formula
Formulation
Stability
Exhibits superior stability in water-based serums and hydrogels. Often encapsulated in nanoethosomes to enhance delivery and maintain the integrity of the peptide-hydrogel complex.
Synergies
- Hyaluronic acid
- Other non-acidic peptides
- Niacinamide
Conflicts
- Strong oxidizing agents
- Extreme acidic environments (pH < 4.0)
- High-strength L-Ascorbic Acid
Safety
Safety Profile
Testing in human dermal fibroblasts confirms the ingredient is non-cytotoxic and well-tolerated at biologically active concentrations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-performance precision peptide that offers measurable improvements in collagen density and enzymatic protection when formulated at 0.05%.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources